Sign In
Buy TDOC
$6.71
+0.130 (+1.98%)
At Close: Jul 31, 2026
Teladoc Health Announces Chief Financial Officer Transition
04:05pm, Thursday, 23'rd Oct 2025
Provides Preliminary Third Quarter 2025 Consolidated Financial Results, Reaffirms Full-Year 2025 Consolidated Outlook Provides Preliminary Third Quarter 2025 Consolidated Financial Results, Reaffirms
Teladoc (TDOC) Expected to Beat Earnings Estimates: Should You Buy?
11:06am, Wednesday, 22'nd Oct 2025
Teladoc (TDOC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analyzing Progyny (NASDAQ:PGNY) & Teladoc Health (NYSE:TDOC)
01:48am, Wednesday, 22'nd Oct 2025
Progyny (NASDAQ: PGNY - Get Free Report) and Teladoc Health (NYSE: TDOC - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses b
Better Beaten-Down Stock: Iovance Biotherapeutics vs. Teladoc Health
06:17am, Friday, 17'th Oct 2025
Here's a great way to earn strong market returns over the long term: Identify companies that have been ignored or underestimated by most investors but have attractive prospects; buy their shares at a
Teladoc Health to Announce Third Quarter 2025 Financial Results
04:30pm, Wednesday, 15'th Oct 2025
NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release third quarter 2025 results on Wednesday, October 29, 202
Can 4 Relative Price Strength Stocks Defy Market Swings?
04:11pm, Wednesday, 15'th Oct 2025
UNFI, TDOC, SUPN and BRP shine with strong relative price strength, earnings momentum, and analyst upgrades amid volatile markets.
Teladoc (TDOC) Recently Broke Out Above the 20-Day Moving Average
10:35am, Wednesday, 15'th Oct 2025
Teladoc (TDOC) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, TDOC crossed above the 20-day moving average, suggesting a sho
Teladoc (TDOC) Just Reclaimed the 200-Day Moving Average
10:31am, Wednesday, 15'th Oct 2025
From a technical perspective, Teladoc (TDOC) is looking like an interesting pick, as it just reached a key level of support. TDOC recently overtook the 200-day moving average, and this suggests a long
Teladoc Health Expands Clarity Platform With Workplace Safety Tool
10:20am, Wednesday, 15'th Oct 2025
TDOC enhances its Clarity platform with an AI-driven tool to help hospitals combat rising workplace violence incidents.
Looking for a Fast-paced Momentum Stock at a Bargain? Consider Teladoc (TDOC)
09:50am, Wednesday, 15'th Oct 2025
Teladoc (TDOC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that ma
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:50am, Wednesday, 15'th Oct 2025
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Teladoc Health Adds Workplace Safety Capability to its AI-Enabled Clarity™ Monitoring Solution for Hospitals and Health Systems
06:00am, Tuesday, 14'th Oct 2025
New offering aims to address the growing threat of workplace violence in healthcare settings, building on Teladoc Health's suite of AI-enabled solutions.
3 Medical Service Industry Stocks Poised to Counter Workforce Issues
12:51pm, Friday, 10'th Oct 2025
Here are three resilient medical services stocks, Labcorp, Charles River Laboratories and Teladoc, that are poised to outperform amid staffing shortages and digital healthcare growth.
Teladoc (TDOC) Stock Drops Despite Market Gains: Important Facts to Note
07:16pm, Monday, 06'th Oct 2025
Teladoc (TDOC) concluded the recent trading session at $8.57, signifying a -4.88% move from its prior day's close.
All You Need to Know About Teladoc (TDOC) Rating Upgrade to Buy
01:01pm, Monday, 06'th Oct 2025
Teladoc (TDOC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
